Építés alatt – nem éles oldal
Belépés

What researchers published on Tripla negatív emlőrák

19 715 papers, newest first.

Showing 20 of 1886

  • Szisztematikus áttekintésPeripheral absolute lymphocyte count and survival of patients with triple-negative breast cancer: a meta-analysis.Frontiers in oncology
  • ÁttekintésEfficacy of adding neoadjuvant pembrolizumab to standard chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis of real-world studies.Pakistan journal of medical sciences
  • ÁttekintésDual-target CAR-T cells in triple-negative breast cancer: recent advances and translational challenges.Frontiers in medicine
  • ÁttekintésPersonalizing Adjuvant Radiotherapy After Complete Response in Locally Advanced Triple-Negative Breast Cancer: Exploring the Potential Role of BRCA Status.Clinical breast cancer
  • ÁttekintésThe Role of Hypoxia-Inducible Factors (HIFs) in Triple-Negative Breast Cancer Radiation Resistance.International journal of molecular sciences
  • MetaanalízisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
  • ÁttekintésRecent Advances in Mitochondria-Targeted Nanoparticle Photodynamic Therapy for Triple-Negative Breast Cancer.International journal of molecular sciences
  • ÁttekintésSQSTM1/p62 and Mitochondrial Stress in Triple-Negative Breast Cancer: A Critical Pathology Perspective.Cancers
  • ÁttekintésCirculating Non-Coding RNAs as Liquid Biopsy Biomarkers for Early Detection of Triple-Negative Breast Cancer: From Diagnostic Performance to Clinical Translation.Diagnostics (Basel, Switzerland)
  • ÁttekintésThe HLA-E-NKG2A axis in breast cancer: an emerging NK-cell checkpoint and therapeutic target.Frontiers in immunology
  • ÁttekintésGlutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer.Cell communication and signaling : CCS
  • MetaanalízisReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis.BMC cancer
  • ÁttekintésBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
  • ÁttekintésAdvanced platinum strategies for triple-negative breast cancer.Trends in pharmacological sciences
  • ÁttekintésResearch progress on the key cuproptosis regulator FDX1 and its relevance to triple-negative breast cancer.Frontiers in molecular biosciences
  • ÁttekintésResidual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy-Pembrolizumab Integration.Cancer management and research
  • ÁttekintésCancer-associated fibroblasts in triple-negative breast cancer: heterogeneity, tumor-stroma crosstalk, and therapeutic resistance.Frontiers in oncology
  • ÁttekintésTargeting triple-negative breast cancer: Molecular basis and emerging antibody-drug conjugate strategies.Biochimica et biophysica acta. Molecular basis of disease
  • ÁttekintésClinical Challenges in Triple-Negative Breast Cancer (TNBC): Current Treatment Options, Their Limitations, and Emerging Perspectives.Cancers
  • ÁttekintésMorphology-Guided Diagnosis of Triple-Negative Breast Carcinoma: From Histopathological Evaluation to Molecular Testing.Journal of clinical medicine